Anti-VEGF Antibody HuMV833: an EORTC Biological Treatment Development Group Phase I Toxicity, Pharmacokinetic and Pharmacodynamic Study.
Gordon C. Jayson,
C Mulatero,
Malcolm Ranson,
Jamal Zweit,
D. L. Hastings,
PJ Julyan,
Jeremy Lawrance,
AT McGown,
Anna Jackson,
Hamied Haroon,
Research Explorer (The University of Manchester) · 2001 · 19 citations · 0 references